Bicycle Therapeutics plc
BCYC
$4.72
$0.020.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -218.96M | -250.66M | -242.36M | -203.22M | -169.03M |
| Total Depreciation and Amortization | 6.42M | 6.79M | 7.21M | 7.15M | 7.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.61M | 30.94M | 30.09M | 30.25M | 30.58M |
| Change in Net Operating Assets | -75.75M | -26.80M | -3.32M | -14.40M | -33.45M |
| Cash from Operations | -249.68M | -239.73M | -208.38M | -180.23M | -164.72M |
| Capital Expenditure | -2.35M | -2.14M | -1.91M | -1.83M | -1.24M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.35M | -2.14M | -1.91M | -1.83M | -1.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -168.00K | -162.00K | -31.99M | -31.95M | -31.91M |
| Issuance of Common Stock | 37.00K | 249.00K | 248.00K | 549.85M | 551.72M |
| Repurchase of Common Stock | -- | -- | -67.00K | -67.00K | -67.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -131.00K | 87.00K | -31.81M | 517.84M | 519.75M |
| Foreign Exchange rate Adjustments | 804.00K | -755.00K | 2.19M | 190.00K | -694.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -251.35M | -242.54M | -239.91M | 335.98M | 353.10M |